Publications by authors named "Emma Link"

Claim this Profile
T
The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer.
Michael Michael, Rachel Wong, Sanjeev Gill, Andrew H Strickland, Nick Pavlakis, Emma Link

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Node-positive carcinoma of the vulva treated with curative-intent radiotherapy.
Julianne O'Shea, Emma Link, Pearly Khaw, David Chang, Krystel Tran

Int J Gynecol Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Nodal Status on Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial.
Michael S Hofman, Veeru Kasivisvanathan, Emma Link, James Buteau, Matthew J Roberts

Eur Urol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma.
Ciara Conduit, Ian D Davis, Jeffrey C Goh, Ganessan Kichenadasse, Howard Gurney, Emma K Link

BJU Int· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study.
Lavinia Tan, Ben Tran, Jeanne Tie, Ben Markman, Sumi Ananda, Emma Link

Clin Cancer Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost? - Authors' reply.
Boon H Chua, Emma K Link, Ian H Kunkler, Ivo A Olivotto

Lancet· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myeloma.
Jake Shortt, Peter Galettis, Chan Y Cheah, Joanne Davis, Mandy Ludford-Menting, Emma K Link

Clin Epigenetics· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
Boon H Chua, Emma K Link, Ian H Kunkler, Timothy J Whelan, A Helen Westenberg

Lancet· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased risk of diaphragmatic herniation following esophagectomy with a minimally invasive abdominal approach.
Adele Hwee Hong Lee, June Oo, Carlos S Cabalag, Emma Link, Cuong Phu Duong

Dis Esophagus· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites.
Zheng Liu, Jennifer H Martin, Winston Liauw, Sue-Anne McLachlan, Emma Link

Eur J Clin Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study.
Michael Michael, Winston Liauw, Sue-Anne McLachlan, Emma Link, Annetta Matera

Cancer Chemother Pharmacol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single well, single-common primer pair, dual probe, duplex qPCR assay for the quantification of mRNA splicing variants.
Janice Wang, Winifred P Wong, Emma O Link, Shantel Olivares, Cade T Adelman

Biol Methods Protoc· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The INTERNET STUDY: A phase II study of everolimus in patients with fluorodeoxyglucose ( F) positron-emission tomography positive intermediate grade pancreatic neuroendocrine tumors.
Mei Sim Lung, Rodney J Hicks, Nick Pavlakis, Emma Link, Michael Jefford

Asia Pac J Clin Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
Madeleine T King, Emma K Link, Tim J Whelan, Ivo A Olivotto, Ian Kunkler

Lancet Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.
Michael S Hofman, Nathan Lawrentschuk, Roslyn J Francis, Colin Tang, Ian Vela, Emma Link

Lancet· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma.
Mizue Terai, Eric Londin, Ankit Rochani, Emma Link, Bao Lam

Cancers (Basel)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast.
Ivo A Olivotto, Emma Link, Claire Phillips, Timothy J Whelan, Guy Bryant

Radiother Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427).
Toan Pham, Lloyd Pereira, Sara Roth, Laura Galletta, Emma Link

Contemp Clin Trials Commun· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study.
Amit Khot, Natalie Brajanovski, Donald P Cameron, Nadine Hein, Kylee H Maclachlan, Emma Link

Cancer Discov· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of 5-fluorouracil pharmacokinetic monitoring using the My-5FU PCM™ system in a quaternary oncology centre.
Michael Moloney, David Faulkner, Emma Link, Danny Rischin, Ben Solomon

Cancer Chemother Pharmacol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study.
Hang Quach, Liam Fernyhough, Ross Henderson, Gillian Corbett, Bart Baker, Emma Link

Br J Haematol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.
Kenneth F Bradstock, Emma Link, Juliana Di Iulio, Jeff Szer, Paula Marlton

J Clin Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Association Between Demographics, SLC30A8 Genotype, and Human Islet Content of Zinc, Cadmium, Copper, Iron, Manganese and Nickel.
Winifred P Wong, Norrina B Allen, Matthew S Meyers, Emma O Link, Xiaomin Zhang

Sci Rep· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML).
Melita Kenealy, Nigel Patton, Robin Filshie, Andrew Nicol, Shir-Jing Ho, Emma Link

Leuk Lymphoma· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Intensity of Pain and Other Physical and Psychological Symptoms in Adolescents and Young Adults Diagnosed with Cancer on Referral to a Palliative Care Service.
Rachel E Hughes, Lucy R Holland, Diana Zanino, Emma Link, Natasha Michael

J Adolesc Young Adult Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis